Henry Stewart Talks: New Additions for July

Please find below a list of the latest additions to The Biomedical & Life Sciences Collection. This month's release includes talks on the academic basis of primary health care by Prof. Trisha Greenhalgh of the University of Oxford, cancer treatment paradigms by Prof. Sharon Marsh of the University of Alberta, Canada, drug metabolizing enzymes in cancer therapeutics by Prof. Bhagwat Prasad of the University of Washington, metabolomics data analysis in the context of metabolic networks by Dr. Fabien Jourdan of the French Agronomic Research Institute, and much more.

The latest addition to the Periodic Reports series is a talk reviewing the current state of Deep Brain Stimulation (DBS) neuromodulation for Schizophrenia, presented by Prof. Judith Gault of the University of Colorado.

Latest releases:

In Topical Talks:

The academic basis of primary health careThe academic basis of primary health care
Prof. Trisha Greenhalgh – University of Oxford, UK

In Bioinformatics for Metabolomics:

Analysis of LCMS-based untargeted metabolomics data 1Analysis of LCMS-based untargeted metabolomics data 1
Analysis of LCMS-based untargeted metabolomics data 2

Dr. Pietro Franceschi – Fondazione Edmund Mach, Italy

Metabolomics data analysis in the context of metabolic networksMetabolomics data analysis in the context of metabolic networks
Dr. Fabien Jourdan – French Agronomic Research Institute, France

In Cancer Therapies in the Personalized Medicine Era:

Drug metabolizing enzymes in cancer therapeuticsDrug metabolizing enzymes in cancer therapeutics
Prof. Bhagwat Prasad – University of Washington, USA

Cancer treatment paradigmsCancer treatment paradigms
Prof. Sharon Marsh – University of Alberta, Canada

In Periodic Reports: Advances in Clinical Interventions and Research Platforms:

Deep Brain Stimulation (DBS) neuromodulation for SchizophreniaDeep Brain Stimulation (DBS) neuromodulation for Schizophrenia
Prof. Judith Gault – University of Colorado, Denver, USA

In Adaptive Clinical Trial:

Patient heterogeneity in dose-finding trials - part 1: methods for 2 groupsPatient heterogeneity in dose-finding trials - part 1: methods for 2 groups

Patient heterogeneity in dose-finding trials - part 2: more than 2 groups

Prof. Mark Conaway – University of Virginia, USA

In The Blood-Brain Barrier:

The blood-brain barrier in multiple sclerosis: A target for treatment?The blood-brain barrier in multiple sclerosis: A target for treatment?
Dr. Elga de Vries – VU Medical Centre, Netherlands

In The Complement System:

Physiopathological implications of genetic variability in the complement alternative pathwayPhysiopathological implications of genetic variability in the complement alternative pathway
Prof. Santiago Rodríguez de Córdoba – Centro de Investigaciones Biológicas, Spain

In Stroke-Prevention:

How to identify which patients with asymptomatic carotid stenosis could benefit from endarterectomy or stentingHow to identify which patients with asymptomatic carotid stenosis could benefit from endarterectomy or stenting
Dr. Kosmas Paraskevas – Athens University Medical School, Greece

Featured talks from previous releases:

The classical pathway of complementThe classical pathway of complement
Prof. Mohamed R. Daha – Leiden University Medical Center, Netherlands

The role of the nurse in supporting health and well-being for people with learning (intellectual) disabilitiesThe role of the nurse in supporting health and well-being for people with learning (intellectual) disabilities
Prof. Ruth Northway – University of South Wales, UK

Parkinson's at 200 years: an update on Parkinson's research in 2017Parkinson's at 200 years: an update on Parkinson's research in 2017
Prof. Patrick A. Lewis – University of Reading, UK